KR910003612B1 - Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives - Google Patents

Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives Download PDF

Info

Publication number
KR910003612B1
KR910003612B1 KR1019870004232A KR870004232A KR910003612B1 KR 910003612 B1 KR910003612 B1 KR 910003612B1 KR 1019870004232 A KR1019870004232 A KR 1019870004232A KR 870004232 A KR870004232 A KR 870004232A KR 910003612 B1 KR910003612 B1 KR 910003612B1
Authority
KR
South Korea
Prior art keywords
acetoxy
general formula
hydroxyethylazetidin
derivative
group
Prior art date
Application number
KR1019870004232A
Other languages
Korean (ko)
Other versions
KR870009994A (en
Inventor
가즈노리 간
노보루 우에야마
이사오 사다
다께히사 오오하시
기요시 와따나베
Original Assignee
가네가후찌가가꾸고오교 가부시끼가이샤
니이노 마비도
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61101856A external-priority patent/JPH0830057B2/en
Priority claimed from JP62028942A external-priority patent/JPH0655717B2/en
Application filed by 가네가후찌가가꾸고오교 가부시끼가이샤, 니이노 마비도 filed Critical 가네가후찌가가꾸고오교 가부시끼가이샤
Publication of KR870009994A publication Critical patent/KR870009994A/en
Application granted granted Critical
Publication of KR910003612B1 publication Critical patent/KR910003612B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

내용 없음.No content.

Description

4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법Method for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative

본 발명은 히드록실기가 보호된 상태인 히드록시에틸기를 C3-위치에 갖으며 또한 아세톡시기를 C4-위치에 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법에 관한 것이다. 상기 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체는 티에나마이신과 같은 카르바페넴 β-락탐 항생물질 및 페넴 β-락탐 항생물질을 제조하는데 있어서의 유용한 중간물질로 공지되어 있다[참조, 예. 테트라헤드론 레터스(Tetrahedron Letters), 라이더(Reider)등, 23권, 2293페이지, 1982 및 Chem. Pharm. Bull. 요시다(Yoshida)등, 29권, 2899페이지. 1981]The present invention provides a 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having a hydroxyethyl group in a protected state of a hydroxyl group at a C3-position and an acetoxy group at a C4-position. It is about a method. The 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives are known as useful intermediates for preparing carbapenem β-lactam antibiotics and penem β-lactam antibiotics such as thienamycin. [See, eg. Tetrarahedron Letters, Reider et al., Vol. 23, p. 2293, 1982 and Chem. Pharm. Bull. Yoshida et al, 29, 2899. 1981]

지금까지 알려진 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 합성 방법으로는, 예를들면 6-아미노페니실란산으로부터 합성하는 방법(참고. Chem. Pharm. Bull. 요시다등, 29권, 2899페이지, 1981), 트레오닌으로부터 합성하는 방법(참고. 테트라헤드론, 시오자끼(shiozaki)등, 39권, 2399페이지, 1983), 아스파르트산으로부터 합성하는 방법(참고. 테트라헤드론 래터스, 라이더등, 23권, 2293페이지, 1982) 및 β-히드록시부티르산의 금속 엔올레이트로부터 합성하는 방법(참고. 캐미스트리레터스, 나까이(Nakai)등, 1927페이지, 1984)이 있다. 그러나 이들 방법들은 아세톡시기를 β-락탐고리의 C4-위치에 도입하기 위해 공업적으로 부적합한 시약들, 예를들면 아세트산 제일수은 또는 황산 제일수은과 같은 수은 화합물 및 테트라아세트산납을 사용하는 문제점을 지니고 있다.As a method for synthesizing the 4-acetoxy-3-hydroxyethylazetidin-2-one derivative known to date, for example, a method for synthesizing from 6-aminophenicylanic acid (see Chem. Pharm. Bull. Yoshida et al. , Vol. 29, p. 2899, 1981), Synthesis from threonine (cf. tetrahedron, shiozaki et al., Vol. 39, p. 2399, 1983), Synthesis from aspartic acid (cf. tetrahedron Laters, Rider et al., Vol. 23, p. 2293, 1982) and methods of synthesis from metal oleates of β-hydroxybutyric acid (cf. chemistry, Nakai et al., 1927, 1984). However, these methods avoid the problem of using industrially unsuitable reagents such as mercury compounds such as mercury acetate or mercury sulfate and lead tetraacetate to introduce acetoxy groups to the C4-position of the β-lactam ring. I have it.

본 발명자들은 O-보호된 히드록시에틸기를 C3-위치에 및 실릴에테르기를 C4-위치에 갖는 N-보호된 β-락탐 화합물을 이용하여 C4-위치에 아세톡시기를 도입하는 방법을 알아내어 특허출원 바 있다(참고. 일본국 특허공개공보 제18758/1986호).The inventors have found and patented a method of introducing an acetoxy group at the C4-position using an N-protected β-lactam compound having an O-protected hydroxyethyl group at the C3-position and a silylether group at the C4-position. (See Japanese Patent Laid-Open No. 18758/1986).

그러나, 상기 방법은 2가지 단계, 즉 β-락탐의 N에 대한 보호기를 미리 도입하는 제1단계, 및 아세톡시기를 C4-위치에 도입한 후 상기 보호기를 제거하기 위한 또다른 제2단계를 거친다.However, the method involves two steps, a first step of introducing a protecting group to N of β-lactam in advance, and another second step of removing the protecting group after introducing an acetoxy group into the C4-position. Rough

따라서, 본 발명자들은 β-락탐의 N을 보호함이 없이 아세톡시기를 C4-위치에 직접 도입할 수 있는 방법을 알아내어 본 발명을 완성하게 되었다.Therefore, the present inventors have found a method for introducing an acetoxy group directly into the C4-position without protecting the N of β-lactam, thereby completing the present invention.

본 발명에 따르면, 하기 일반식(Ⅰ)을 갖는 β-락탐 화합물을 아세트산 무수물과 낮은 농도의 치환된 피리딘 존재하의 유기용매내에서 반응시킴을 특징으로 하는 하기 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법을 제공한다.According to the present invention, 4-acetic acid having the following general formula (II) characterized by reacting a β-lactam compound having the general formula (I) in an organic solvent in the presence of acetic anhydride and a low concentration of substituted pyridine Provided is a method for preparing a oxy-3-hydroxyethylazetidin-2-one derivative.

Figure kpo00001
Figure kpo00001

Figure kpo00002
Figure kpo00002

(식중, R1은 히드록실기에 대한 보호기이고, 및 R2, R3및 R4는 탄소수 1∼6의 저급알킬기, 페닐기 또는 아르알킬기이다.)(Wherein R 1 is a protecting group for a hydroxyl group, and R 2 , R 3 and R 4 are lower alkyl groups, phenyl groups or aralkyl groups having 1 to 6 carbon atoms.)

본 발명자들이 선출원(일본국 특허공개공보 제19791/1986호)에서 개시한 바와 같이, C4-위치에 실릴에테르기를 갖는 β-락탐 화합물(Ⅰ)은 이하에 나타내는 반응도식의 공정에 따라 쉽게 수득할 수 있다:As the inventors have disclosed in the prior application (Japanese Patent Laid-Open No. 1831/1986), the β-lactam compound (I) having a silyl ether group at the C4-position can be easily obtained according to the reaction scheme shown below. Can:

Figure kpo00003
Figure kpo00003

β-락탐 화합물(Ⅰ)의 C3-위치에 존재하는 히드록시에틸기를 나타내는 R1의 O-보호기의 예로서 하기 일반식(Ⅲ)을 갖는 트리알킬실릴기를 들 수 있다:Examples of the O-protecting group of R 1 representing the hydroxyethyl group present at the C3-position of the β-lactam compound (I) include a trialkylsilyl group having the following general formula (III):

Figure kpo00004
Figure kpo00004

식중, R5, R6및 R7은 탄소수 1∼6의 저급알킬기로서, 그의 예에는 t-부틸디메틸실릴기, 트리이소프로필실릴기, 이소프로필디메틸실릴기, 이소부틸디메틸실릴기, 1, 2-디메틸프로필디메틸실릴기, 디메틸-1, 1, 2-트리메틸-프로필실릴기, t-부틸기, 벤질기, 트리클로로에톡시카르보닐기, t-부톡시카르보닐기, p-니트로벤질옥시카르보닐기 등이 속한다. 이들중, t-부틸디메틸실릴기, 이소프로필디메틸실릴기 및 디메틸-1, 1, 2-트리메틸프로필실릴기가 반응실시공정동안 안정하며 또한 산처리하여 선택적으로 제거할 수 있다는 것들로 인해 가장 바람직하다. 일반식(Ⅰ)을 갖는 β-락탐 화합물의 기 R2, R3및 R4는 서로 동일하거나 다르며, 메틸, 에틸, 이소프로필, 이소부틸, t-부틸 또는 1, 1, 2-트리메틸프로필기와 같은 탄소수 1∼6의 저급알킬기, 페닐기, 또는 벤질기와 같은 아르알킬기, p-니트로벤질기로부터 선택된다. R2, R3및 R4가 모두 메틸기인 것이 바람직하다.Wherein R 5 , R 6 and R 7 are lower alkyl groups having 1 to 6 carbon atoms, and examples thereof include t-butyldimethylsilyl group, triisopropylsilyl group, isopropyldimethylsilyl group, isobutyldimethylsilyl group, 1, 2-dimethylpropyldimethylsilyl group, dimethyl-1, 1, 2-trimethyl-propylsilyl group, t-butyl group, benzyl group, trichloroethoxycarbonyl group, t-butoxycarbonyl group, p-nitrobenzyloxycarbonyl group, etc. Belongs. Of these, t-butyldimethylsilyl group, isopropyldimethylsilyl group and dimethyl-1,1,2-trimethylpropylsilyl group are most preferred because they are stable during the reaction process and can be selectively removed by acid treatment. . The groups R 2 , R 3 and R 4 of the β-lactam compound having the general formula (I) are the same or different from each other, and are methyl, ethyl, isopropyl, isobutyl, t-butyl or 1, 1, 2-trimethylpropyl group. Aralkyl groups such as lower alkyl groups having 1 to 6 carbon atoms, phenyl groups, or benzyl groups, and p-nitrobenzyl groups. It is preferable that all of R 2 , R 3 and R 4 are methyl groups.

상술한 바와 같이하여 제조된, 하기 일반식(Ⅰ)을 갖는 β-락탐 화합물을 아세트산 무수물과 유기용매내에서 낮은 농도의 치환된 피리딘 존재하에 반응시킴으로써 β-락탐 화합물(Ⅰ)을 목적하는 하기 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체로 변환시킨다.A β-lactam compound (I) prepared as described above by reacting a β-lactam compound having the following general formula (I) in the presence of a low concentration of substituted pyridine in acetic anhydride and an organic solvent It is converted into a 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having the formula (II).

Figure kpo00005
Figure kpo00005

(식중, R1, R2, R3및 R4는 상기에서 정의한바와 같다.) 상술한 반응에 있어서, 목적 화합물을 충분한 수율로 수득하기 위해서는 반응계내의 치환된 피리딘의 농도가 고려하여야할 중요한 요인으로서, 가장 알맞은 농도로 결정하여야 한다.(Wherein R 1 , R 2 , R 3 and R 4 are as defined above.) In the above reaction, the concentration of substituted pyridine in the reaction system is an important factor to be considered in order to obtain the desired compound in sufficient yield. As a result, the most appropriate concentration should be determined.

본 발명에서 사용하는 치환된 피리딘으로서는 4-디메틸아미노피리딘 또는 4-디메틸아미노피리딘과 같은 디알킬아미노피리딘 및 질소원자를 함유하는 헤테로고리기를 치환체로 갖는 치환된 피리딘으로서의 4-피롤리디노피리딘 또는 4-피페리디노피리딘이 바람직하다. 반응계내의 치환된 피리딘의 농도는 0.2∼3중량%가 바람직하다. 이때, 0.2중량%이하일 경우 반응속도가 저하되고 기질분해의 부반응이 심각하게 발생한다.As the substituted pyridine used in the present invention, 4-pyrrolidinopyridine or 4 as a substituted pyridine having a heterocyclic group containing a dialkylaminopyridine and a nitrogen atom as 4-dimethylaminopyridine or 4-dimethylaminopyridine as a substituent or 4 -Piperidinopyridine is preferred. The concentration of substituted pyridine in the reaction system is preferably 0.2 to 3% by weight. At this time, if less than 0.2% by weight, the reaction rate is lowered and side reactions of substrate decomposition occur seriously.

반면에 농도가 3중량%이상일 경우에는, 하기 일반식(Ⅳ)를 갖는 부-생성물의 수율이 증가되고, 또한 목적화합물이 충분한 수율로 수득되지 않는다.On the other hand, when the concentration is 3% by weight or more, the yield of the sub-product having the following general formula (IV) is increased, and the desired compound is not obtained in sufficient yield.

Figure kpo00006
Figure kpo00006

(식중, R1은 상기에서 정의한 바와 같다.)Wherein R 1 is as defined above.

본 발명에 있어서, 아세트산 무수물이 치환된 피리딘에 비해 보다 소량일 경우 반응속도가 저하되므로 아세트산 무수물을 치환된 피리딘보다 다량 사용한다. 바람직하기로는, 아세트산 무수물이 10∼50중량%의 양으로 반응계내에 존재하도록 사용한다. 반응용매로서는 염화메틸렌 또는 사염화탄소와 같은 할로겐화 탄화수소, n-헥산과 같은 탄화수소, 톨루엔과 같은 방향족 탄화수소, 에틸아세테이트, 테트라히드로푸란 및 테트라히드로피란을 사용하는 것이 바람직하다. 피리딘, 피콜린, 루티딘, 디에틸에테르, 디글림, 디메틸포름아미드, 아세톤 등도 또한 반응용매로 사용할 수 있다.In the present invention, when the acetic anhydride is smaller than the substituted pyridine, the reaction rate is lowered, so that acetic anhydride is used in a larger amount than the substituted pyridine. Preferably, acetic anhydride is used in the reaction system in an amount of 10 to 50% by weight. As the reaction solvent, it is preferable to use halogenated hydrocarbons such as methylene chloride or carbon tetrachloride, hydrocarbons such as n-hexane, aromatic hydrocarbons such as toluene, ethyl acetate, tetrahydrofuran and tetrahydropyran. Pyridine, picoline, lutidine, diethyl ether, diglyme, dimethylformamide, acetone and the like can also be used as the reaction solvent.

목적 화합물(Ⅱ)를 충분한 수율로 수득하기 위해서는 0∼-70℃범위내에 낮은 온도에서 반응을 수행한다. -10∼-60℃범위내의 온도에서 반응을 수행하는 것이 바람직하다.In order to obtain the desired compound (II) in sufficient yield, the reaction is carried out at a low temperature within the range of 0 to -70 캜. It is preferable to carry out the reaction at a temperature in the range of -10 to -60 캜.

반응은, 실릴에테르기를 C4-위치에 갖는 β-락탐 화합물(Ⅰ)을 염화메틸렌 또는 톨루엔과 같은 유기용매내에 용해시키고, 혼합물을 냉각시킨 다음, 이어서 아세트산 무수물 및 4-디메틸아미노피리딘과 같은 치환된 피리딘을 한꺼번에 또는 수회로 나누어 첨가함으로써 수행된다. 이어서 얇은 막 크로마토그래피로 관찰하면서 반응을 진행시키고, 출발물질이 소멸되거나 또는 거의 대부분이 소멸되었을 때 반응 혼합물을 물에 부가한다. 유기층을 탄산수소나트륨 및 물로 세정하고, 이어서 황산마그네슘으로 건조시킨다. 용매를 증류제거하여 조 결정체들을 수거한 후, n-헥산등으로 재결정하여 목적하는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체를 수득한다. 또는, 용매를 증발시킨 후 수득되는 반응 혼합물을 컬럼 크로마토그래피하여 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체를 수득할 수도 있다.The reaction is carried out by dissolving β-lactam compound (I) having a silylether group in the C4-position in an organic solvent such as methylene chloride or toluene, cooling the mixture, and then replacing substituted acetic anhydride and 4-dimethylaminopyridine. This is done by adding pyridine all at once or in portions. The reaction is then advanced while observing with thin membrane chromatography and the reaction mixture is added to water when the starting material is extinguished or almost all is extinguished. The organic layer is washed with sodium bicarbonate and water and then dried over magnesium sulfate. The solvent is distilled off to collect crude crystals, and then recrystallized with n-hexane or the like to obtain the desired 4-acetoxy-3-hydroxyethylazetidin-2-one derivative. Alternatively, the reaction mixture obtained after evaporating the solvent may be column chromatographed to obtain 4-acetoxy-3-hydroxyethylazetidin-2-one derivative.

또한, 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체를 고수율로 수득할 수 있는 또다른 방법으로서, 일반식(Ⅰ)을 갖는 β-락탐 화합물을 아세트산 무수물과 유기용매내에서 낮은 농도의 치환된 피리딘 존재하에 반응시킬때에 낮은 농도의 물 또는 아세트산을 첨가하면 목적 화합물의 수율이 증대된다.Further, as another method for obtaining a 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) in high yield, a β-lactam compound having general formula (I) When the reaction is carried out in the presence of acetic anhydride and low concentration of substituted pyridine in an organic solvent, the addition of low concentration of water or acetic acid increases the yield of the target compound.

하기 일반식(Ⅰ)을 갖는 β-락탐 화합물을 치환된 피리딘 및 아세트산 무수물과 유기용매내에서 낮은 용도의 물 또는 아세트산 존재하에 반응시킴으로써 β-락탐 화합물이 하기 일반식(Ⅱ)를 갖는 목적하는 4-아세톡시-3-히드록시 에틸아제티딘-2-온 유도체로 변환된다.A β-lactam compound having the following general formula (II) is reacted by reacting a β-lactam compound having the general formula (I) with substituted pyridine and acetic anhydride in the presence of low use water or acetic acid in an organic solvent. Is converted to an acetoxy-3-hydroxy ethylazetidin-2-one derivative.

Figure kpo00007
Figure kpo00007

(식중, R1, R2, R3및 R4는 상기에서 정의한 바와 같다.) 상술한 반응에 있어서는, 목적 화합물을 충분한 수율로 수득하는데 있어서 반응용매내의 물 또는 아세트산의 농도가 고려하여야할 중요한 요인으로서, 가장 알맞은 농도를 선택 결정한다.(Wherein R 1 , R 2 , R 3 and R 4 are as defined above.) In the above-mentioned reaction, the concentration of water or acetic acid in the reaction solvent is important to obtain the desired compound in sufficient yield. As a factor, select and determine the most appropriate concentration.

반응용매내의 물의 농도는 0.1∼1.0부피%가 바람직하며, 아세트산의 농도는 0.6∼5.0부피%가 바람직하다. 물 또는 아세트산의 농도가 상술한 범위보다 낮을 경우, 하기 일반식(Ⅳ)를 갖는 부-생성물의 수율이 높게 된다.The concentration of water in the reaction solvent is preferably 0.1 to 1.0% by volume, and the concentration of acetic acid is preferably 0.6 to 5.0% by volume. When the concentration of water or acetic acid is lower than the above-mentioned range, the yield of the sub-product having the following general formula (IV) is high.

Figure kpo00008
Figure kpo00008

(식중, R1은 상기에서 정의한 바와 같다.)반면, 물 또는 아세트산의 농도가 상술한 범위보다 높을 경우 기질 분해의 부반응이 심각하게 발생한다. 결과적으로, 목적 화합물을 충분한 수율로 수득할 수 없다.Wherein, R 1 is as defined above. On the other hand, when the concentration of water or acetic acid is higher than the above-mentioned range, side reaction of substrate decomposition occurs seriously. As a result, the desired compound cannot be obtained in sufficient yield.

상술한 본 발명의 반응에서 사용하는 치환된 피리딘으로서는, 예를들면 4-디메틸아미노피리딘 또는 4-디에틸아미노피리딘과 같은 디알킬아미노피리딘, 및 질소원자를 함유하는 헤테로고리기를 치환체로 갖는 치환된 피리딘으로서의 4-피롤리디노피리딘 또는 4-피페리디노피리딘이 바람직하다. 반응계내의 치환된 피리딘의 농도는 0.2∼3중량% 범위이내가 바람직하다.Substituted pyridines used in the reaction of the present invention described above include, for example, dialkylaminopyridine such as 4-dimethylaminopyridine or 4-diethylaminopyridine, and a substituted heterocyclic group containing a nitrogen atom as a substituent. Preferred is 4-pyrrolidinopyridine or 4-piperidinopyridine as pyridine. The concentration of substituted pyridine in the reaction system is preferably within the range of 0.2 to 3% by weight.

본 발명에 있어서, 아세트산 무수물의 양이 치환된 피리딘에 비해 보다 소량일 경우 반응속도가 저하되므로 아세트산 무수물을 치환된 피리딘보다 다량으로 사용한다. 바람직하기로는, 아세트산 무수물을 10∼50중량%에 달하는 양으로 반응계내에서 사용한다. 반응용매로서는 염화메틸렌 또는 사염화탄소와 같은 할로겐화 탄화수소, n-헥산과 같은 탄화수소, 톨루엔과 같은 방향족 탄화수소, 에틸아세테이트, 테트라히드로푸란 및 테트라히드로피란을 사용하는 것이 바람직하다. 또는, 피리딘, 피콜린, 루티딘, 디에틸에테르, 디글림, 디메틸포름아미드, 아세톤 등을 반응용매로 사용할 수도 있다.In the present invention, when the amount of acetic anhydride is smaller than the substituted pyridine, the reaction rate is lowered, so that acetic anhydride is used in a larger amount than the substituted pyridine. Preferably, acetic anhydride is used in the reaction system in an amount of up to 10 to 50% by weight. As the reaction solvent, it is preferable to use halogenated hydrocarbons such as methylene chloride or carbon tetrachloride, hydrocarbons such as n-hexane, aromatic hydrocarbons such as toluene, ethyl acetate, tetrahydrofuran and tetrahydropyran. Alternatively, pyridine, picoline, lutidine, diethyl ether, diglyme, dimethylformamide, acetone and the like can also be used as the reaction solvent.

목적 화합물(Ⅱ)를 충분한 수율로 수득하기 위해서는 0∼-70℃범위내에 낮은 온도에서 반응을 수행한다. 바람직하기로는, -10℃∼-60℃범위내의 온도에서 반응을 수행한다.In order to obtain the desired compound (II) in sufficient yield, the reaction is carried out at a low temperature within the range of 0 to -70 캜. Preferably, the reaction is carried out at a temperature in the range of -10 ° C to -60 ° C.

반응은, 실릴에테르기를 C4-위치에 갖는 β-락탐 화합물(Ⅰ)을 테트라히드로푸란 또는 에틸아세테이트와 같은 유기용매내에 용해시키고, 혼합물을 냉각시킨 후, 적당량의 물 또는 아세트산을 가하고, 이어서 상술한 온도에서 아세트산 무수물 및 4-디메틸아미노피리딘과 같은 치환된 피리딘을 한꺼번에 또는 수회로 나누어 첨가함으로써 수행된다. 이어서 얇은 막 크로마토그래피로 관찰하면서 반응을 진행시키고, 출발물질이 소멸되거나 또는 거의 소멸되었을 때 반응 혼합물을 물에 가한다. 유기층을 탄산수소나트륨 및 물로 세정하고, 황산마그네슘으로 건조시킨다. 용매를 증류제거하여 조결정체들을 수득한 후, n-헥산등으로 재결정하여 목적하는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체가 수득된다. 또는, 상기 조결정체들을 컬럼 크로마토그래피하여 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체를 수득할 수도 있다.The reaction is performed by dissolving β-lactam compound (I) having a silyl ether group in the C4-position in an organic solvent such as tetrahydrofuran or ethyl acetate, cooling the mixture, and then adding an appropriate amount of water or acetic acid, and then It is carried out by the addition of substituted pyridine such as acetic anhydride and 4-dimethylaminopyridine at once or in portions at temperatures. The reaction is then advanced while observing with thin membrane chromatography and the reaction mixture is added to water when the starting material is extinguished or almost extinguished. The organic layer was washed with sodium bicarbonate and water, and dried over magnesium sulfate. The solvent is distilled off to obtain crude crystals, and then recrystallized with n-hexane or the like to obtain the desired 4-acetoxy-3-hydroxyethylazetidin-2-one derivative. Alternatively, the crude crystals may be column chromatographed to obtain 4-acetoxy-3-hydroxyethylazetidin-2-one derivative.

이하에서는 비-제한예들을 기술하여 본 발명을 보다 상세히 설명하고자 한다. 그러나, 본 발명의 범위 및 핵심을 벗어나지 않는 범위내에서 임의의 변형 또는 전개가 가능하다는 것을 밝혀두는 바이다.The following describes the present invention in more detail by describing non-limiting examples. However, it will be appreciated that any modification or development is possible without departing from the scope and spirit of the present invention.

[실시예 1]Example 1

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온(융점:95~96℃, [α]D 25=-9.5°(c=1.0, CHCI3)) 157㎎을 염화메틸렌 0.9㎖에 용해시킨후, 혼합물은 -35℃로 냉각시킨다. 이어서, 아세트산 무수물 544㎎ 및 4-디메틸아미노피리딘 20㎎(농도:1.05중량%)을 가하고, 혼합물을 -35℃에서 1일 낮과 밤동안 교반한다. 반응이 완결된 후, NaHCO35% 수용액을 부가하고, 혼합물을 분리한다. 유기층을 물로 세정하고, 황산마그네슘으로 건조시킨 후, 용매를 감압하에 증류제거하여 왁스성 고체 147㎎이 수득되었다.(3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one (melting point: 95-96 ° C, [α] D 25 =- 9.5 ° (c = 1.0, CHCI 3 )) 157 mg is dissolved in 0.9 ml of methylene chloride, and the mixture is cooled to -35 ° C. Then 544 mg of acetic anhydride and 20 mg of 4-dimethylaminopyridine (concentration: 1.05 wt%) are added, and the mixture is stirred at −35 ° C. for 1 day and night. After the reaction is complete, 5% aqueous NaHCO 3 solution is added and the mixture is separated. The organic layer was washed with water, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure to yield 147 mg of a waxy solid.

반응 혼합물을 고속 액체 컬럼 크로마토그래피[컬럼:YMC-pak(A-303 0DS), 4.6×250㎜, 컬럼 온도:50℃, 용매:메탄올/물=7/3(v/v), 유동율:1㎖/분, 검출:210㎚]로 분석한 결과, (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 72.5㎎(수율:51.0%)으로 밝혀졌다.The reaction mixture was subjected to high performance liquid column chromatography [column: YMC-pak (A-303 0DS), 4.6 × 250 mm, column temperature: 50 ° C., solvent: methanol / water = 7/3 (v / v), flow rate: 1 Ml / min, detection: 210 nm]; 72.5 mg of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one (Yield: 51.0%).

이어서, 반응 혼합물을 n-헥산내에 용해시키고, 불용물질을 여거한다. 혼합물을 -15℃에서 냉각시키며 방치하여 백색고체 44㎎이 수득되었다. 수득된 고체는 이하에 나타내는 그의 특성등을 근거로하여 목적하는 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온으로 확인되었다.The reaction mixture is then dissolved in n-hexane and the insolubles are filtered off. The mixture was left to cool at −15 ° C. to yield 44 mg of white solid. The obtained solid was the desired (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one on the basis of the characteristics shown below. It was confirmed.

[α]D 25=+50°(c=0.5, CHCI3)[α] D 25 = + 50 ° (c = 0.5, CHCI 3 )

mp:107∼108℃mp: 107-108 degreeC

1H-NMR(90㎒, CDCL3), δ(ppm):0.08(6H, s), 0.84(9H, s), 1.20(3H, d), 2.10(3H, s), 3.04(1H, dd), 4.12(1H, m), 5.76(1H, d), 6.73(NH) 1 H-NMR (90 MHz, CDCL 3 ), δ (ppm): 0.08 (6H, s), 0.84 (9H, s), 1.20 (3H, d), 2.10 (3H, s), 3.04 (1H, dd ), 4.12 (1H, m), 5.76 (1H, d), 6.73 (NH)

[실시예 2]Example 2

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온 156㎎을 톨루엔 3.6㎖에 용해시킨후, 혼합물은 -35℃로 냉각시킨다. 이어서, 아세트산 무수물 782㎎ 및 4-디메틸아미노피리딘 30㎎(농도:0.73중량%)을 가하고, 혼합물을 -35℃에서 43시간동안 교반한다. 반응 및 실시예1에서와 동일한 처리가 완결된 후, 실시예1에서 이용한 고속액체 크로마토그래피로 반응 혼합물을 분석한 결과, (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 72㎎이 관찰되었다(수율:51.0%).After dissolving 156 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one in 3.6 ml of toluene, the mixture was -35. Cool to ° C. Then 782 mg of acetic anhydride and 30 mg of 4-dimethylaminopyridine (concentration: 0.73 wt%) are added, and the mixture is stirred at −35 ° C. for 43 hours. After the reaction and the same treatment as in Example 1 were completed, the reaction mixture was analyzed by high-performance liquid chromatography used in Example 1, whereupon (3R, 4R) -4-acetoxy-3-[(R) -1 72 mg of -t-butyldimethylsilyloxyethyl] azetidin-2-one was observed (yield: 51.0%).

상기, 반응 혼합물을 실리카-겔 컬럼 크로마토그래피(헥산:에틸아세테이트=10:1)로 정제하여 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 65㎎이 바늘체로 수득되었다.The reaction mixture was purified by silica-gel column chromatography (hexane: ethyl acetate = 10: 1) to give (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxy 65 mg of ethyl] azetidin-2-one were obtained in a needle body.

[실시예 3∼13 및 비교예][Examples 3 to 13 and Comparative Examples]

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

출발물질로서 (3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온을 사용하고, 이하의 표1에 나타낸 조건들하에 치환된 피리딘으로서 각기 다른 농도의 4-디메틸아미노피리딘, 4-피롤리디노피리딘 또는 피페리디노피리딘을 사용하여 실시예1의 공정으로 반응을 수행한 결과 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸-실릴옥시에틸]아제티딘-2-온이 수득되었다.Using (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one as starting material, the conditions shown in Table 1 below The reaction was carried out in the process of Example 1 using different concentrations of 4-dimethylaminopyridine, 4-pyrrolidinopyridine or piperidinopyridine as substituted pyridine under (3R, 4R) -4-acetoxy 3-[(R) -1-t-butyldimethyl-silyloxyethyl] azetidin-2-one was obtained.

실시예1에서 이용한 고속 액체 크로마토그래피로 분석하여 수율을 측정하였다.The yield was measured by analysis by high performance liquid chromatography used in Example 1.

반응 조건들 및 생성물의 수율은 이하의 표1에 나타내는 바와 같다.The reaction conditions and the yield of the product are as shown in Table 1 below.

[표 1]TABLE 1

Figure kpo00009
Figure kpo00009

[실시예 14 및 15]EXAMPLE 14 AND 15

출발물질로서 이하의 표2에 나타내는 4-알킬실릴옥시아제티딘-2-온(화합물(A))을 사용하고, 실시예1에서와 동일한 조건들하에 동일한 공정를 실시한 결과 4-아세톡시아제티딘-2-온(화합물(B))이 수득되었다.4-acetoxyazetidine as a starting material was subjected to the same process under the same conditions as in Example 1, using 4-alkylsilyloxyazetidin-2-one (compound (A)) shown in Table 2 below. 2-one (Compound (B)) was obtained.

화합물(B)의 수율은 이하의 표2에 나타내는 바와 같다.The yield of compound (B) is as showing in Table 2 below.

[표 2]TABLE 2

Figure kpo00010
Figure kpo00010

[실시예 16]Example 16

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온 157㎎을 테트라히드로푸란 1.6㎖에 용해시킨후, 혼합물을 -35℃로 냉각시킨다. 이어서, 물 0.005㎖(농도:0.31부피%), 아세트산무수물 0.5㎖ 및 4-디메틸아미노피리딘 20㎎(농도:0.93중량%)을 가하고, 혼합물을 -35℃에서 22시간동안 교반한다. 반응이 완결된 후, 에틸아세테이트 및 NaHCO35% 수용액을 가하고, 혼합물을 분리한다. 유기층을 물로 세정하고, 용매를 감압하에 증류제거하여 고체 14㎎이 수거되었다.After dissolving 157 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one in 1.6 ml of tetrahydrofuran, the mixture was dissolved. Cool to -35 ° C. Subsequently, 0.005 ml of water (concentration: 0.31% by volume), 0.5 ml of acetic anhydride and 20 mg of 4-dimethylaminopyridine (concentration: 0.93% by weight) are added, and the mixture is stirred at -35 ° C for 22 hours. After the reaction was completed, ethylacetate and 5% aqueous NaHCO 3 solution were added, and the mixture was separated. The organic layer was washed with water, and the solvent was distilled off under reduced pressure to collect 14 mg of solid.

반응 혼합물을 고속 액체 컬럼 크로마토그래피[컬럼:YMC-pak(A-303 0DS), 4.6×250㎜, 컬럼 온도:15℃, 용매:CH3/물=6/4(v/v), 유동율:1㎖/분, 검출:210㎚]로 분석한 결과(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 99.5㎎(수율:70%)이 수득되었다.The reaction mixture was subjected to high performance liquid column chromatography [column: YMC-pak (A-303 0DS), 4.6 × 250 mm, column temperature: 15 ° C., solvent: CH 3 / water = 6/4 (v / v), flow rate: 1 ml / min, detection: 210 nm] (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one 99.5 mg (Yield: 70%) was obtained.

이어서, 반응 혼합물을 n-헥산내에 용해시키고, 불용물질을 여거한다. 혼합물을 -15℃에서 냉각시키며 방치하여 백색고체 89㎎이 수득되었다. 수득된 고체는 이하에 나타내는 그의 특성등을 근거로하여 목적하는 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온으로 확인되었다.The reaction mixture is then dissolved in n-hexane and the insolubles are filtered off. The mixture was left to cool at −15 ° C. to yield 89 mg of white solid. The obtained solid was the desired (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one on the basis of the characteristics shown below. It was confirmed.

[α]D 25=+50°(c=0.5, CHCI3)[α] D 25 = + 50 ° (c = 0.5, CHCI 3 )

mp:107∼108℃mp: 107-108 degreeC

1H-NMR(90㎒, CDCl3), δ(ppm):0.08(6H, s), 0.84(9H, s), 1.20(3H, d), 2.10(3H, s), 3.04(1H, dd), 4.12(1H, m), 5.76(1H, d), 6.78(NH) 1 H-NMR (90 MHz, CDCl 3 ), δ (ppm): 0.08 (6H, s), 0.84 (9H, s), 1.20 (3H, d), 2.10 (3H, s), 3.04 (1H, dd ), 4.12 (1H, m), 5.76 (1H, d), 6.78 (NH)

[실시예 17]Example 17

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온 156㎎을 에틸아세테이트 1.6㎖에 용해시킨후, 혼합물을 -35℃로 냉각시킨다. 이어서, 물 0.005㎖(농도:0.31부피%), 아세트산무수물 0.5㎖ 및 4-디메틸아미노피리딘 30㎎(농도:1.38중량%)을 가한다. 혼합물을 -35℃에서 21시간동안 교반한다. 반응 및 실시예16에서와 동일한 처리가 완결된 후, 실시예16에서 이용한 고속 액체 크로마토그래피로 분석하여 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 85㎎(수율 60%)이 수거된 것으로 확인되었다. n-헥산으로 재결정하여 상술한 화합물 76㎎이 바늘체로 수득되었다.156 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one was dissolved in 1.6 ml of ethyl acetate, and the mixture was- Cool to 35 ° C. Subsequently, 0.005 ml of water (concentration: 0.31% by volume), 0.5 ml of acetic anhydride and 30 mg of 4-dimethylaminopyridine (concentration: 1.38% by weight) are added. The mixture is stirred at −35 ° C. for 21 hours. After completion of the reaction and the same treatment as in Example 16, it was analyzed by high performance liquid chromatography used in Example 16 to give (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethyl 85 mg (yield 60%) of silyloxyethyl] azetidin-2-one were collected. Recrystallization with n-hexane gave 76 mg of the above-mentioned compound as a needle.

[실시예 18]Example 18

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온 156㎎을 에틸아세테이트 1.6㎖에 용해시킨 후, 혼합물을 -35℃로 냉각시키고, 이어서 아세트산 0.03㎖(농도:1.84부피%), 아세트산 무수물 0.5㎖ 및 4-디메틸아미노피리딘 30㎎(농도:1.36중량%)을 가한다. 혼합물을 -35℃에서 21시간동안 교반한다. 반응 및 실시예16에서와 동일한 처리가 완결된 후, 실시예16에서 이용한 고속 액체 크로마토그래피로 분석한 결과 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 83㎎(수율:59%)이 수거된 것으로 나타났다.After dissolving 156 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one in 1.6 ml of ethyl acetate, the mixture was- After cooling to 35 ° C., 0.03 ml of acetic acid (concentration: 1.84% by volume), 0.5 ml of acetic anhydride and 30 mg of 4-dimethylaminopyridine (concentration: 1.36% by weight) are added. The mixture is stirred at −35 ° C. for 21 hours. After completion of the reaction and the same treatment as in Example 16, the result was analyzed by high performance liquid chromatography used in Example 16 to obtain (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyl 83 mg (yield: 59%) of dimethylsilyloxyethyl] azetidin-2-one were collected.

[실시예 19]Example 19

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온 155㎎을 테트라히드로푸란 1.6㎖에 용해시키고, 혼합물을 -35℃로 냉각시킨다. 이어서 아세트산 0.03㎖(농도:1.84부피%), 아세트산 무수물 0.5㎖ 및 4-디메틸아미노피리딘 20㎎(농도:0.92중량%)을 가한다. 혼합물을 -35℃에서 22시간동안 교반한다. 실시예16에서와 동일한 처리를 실시한 후, 실시예16에서 이용한 고속 액체 크로마토그래피로 분석한 결과, (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 84㎎(수율 60%)이 수득된 것으로 나타났다.155 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one was dissolved in 1.6 ml of tetrahydrofuran and the mixture was Cool to 35 ° C. Then 0.03 ml of acetic acid (concentration: 1.84% by volume), 0.5 ml of acetic anhydride and 20 mg of 4-dimethylaminopyridine (concentration: 0.92% by weight) are added. The mixture is stirred at −35 ° C. for 22 hours. After the same treatment as in Example 16, the result was analyzed by high performance liquid chromatography used in Example 16, and the results were (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyl. 84 mg (60% yield) of oxyethyl] azetidin-2-one were obtained.

[실시예 20]Example 20

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

실시예 16의 공정을 반복하여 실시하되, 물 0.005㎖ 대신에 0.01㎖(농도:0.62부피%)를 사용한다. 반응계내의 4-디메틸아미노피리딘의 농도는 0.93중량%이도록 한다.The process of Example 16 was repeated, but 0.01 mL (concentration: 0.62% by volume) was used instead of 0.005 mL of water. The concentration of 4-dimethylaminopyridine in the reaction system is 0.93% by weight.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 수율은 65%이었다.The yield of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one obtained was 65%.

[실시예 21]Example 21

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

실시예 16의 공정을 반복하여 실시하되, 물 0.005㎖ 대신에 아세트산 0.006㎖(농도:3.6부피%)를 사용한다. 반응계내의 4-디메틸아미노피리딘의 농도는 0.91중량%이도록 한다.The process of Example 16 was repeated, but instead of 0.005 mL of water, 0.006 mL of acetic acid (concentration: 3.6% by volume) was used. The concentration of 4-dimethylaminopyridine in the reaction system is 0.91% by weight.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 수율은 66%이었다.The yield of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one obtained was 66%.

[실시예 22∼24][Examples 22 to 24]

출발물질로서 이하의 표3에 나타내는 4-알킬실릴옥시아제티딘-2-온(화합물(A))을 사용하고, 실시예17에서와 동일한 반응 및 처리를 실시한 결과 4-아세톡시아제티딘-2-온(화합물(B))이 수득되었다.As a starting material, 4-acetoxyazetidine- was subjected to the same reaction and treatment as in Example 17, using 4-alkylsilyloxyazetidin-2-one (Compound (A)) shown in Table 3 below. 2-one (Compound (B)) was obtained.

수율은 이하의 표3에 나타내는 바와 같다.The yield is as Table 3 below.

[표 3]TABLE 3

Figure kpo00011
Figure kpo00011

[실시예 25]Example 25

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸-4-트리메틸실릴옥시]아제티딘-2-온 311.3㎎을 피리딘 3.2㎖에 용해시키고, 혼합물을 -50℃로 냉각시킨다. 이어서, 아세트산 무수물 0.3㎖, 4-디메틸아미노피리딘 30㎎(농도:0.79중량%) 및 물 0.01㎖(농도:0.31부피%)를 가하고, 혼합물을 -50℃에서 18.5시간동안 교반한다. 반응이 완결된 후, 헥산 및, 시트르산과 탄산수소나트륨의 완충용액을 가하고, 혼합물을 분리한다.311.3 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl-4-trimethylsilyloxy] azetidin-2-one is dissolved in 3.2 ml of pyridine and the mixture is -50 deg. Cool to Then 0.3 ml of acetic anhydride, 30 mg of 4-dimethylaminopyridine (concentration: 0.97 wt%) and 0.01 ml of water (concentration: 0.31 vol%) are added, and the mixture is stirred at -50 ° C for 18.5 hours. After the reaction is completed, hexane and a buffer solution of citric acid and sodium bicarbonate are added, and the mixture is separated.

유기층을 물로 세정하고, 용매를 감압하에 증류제거하여 고체 294.9㎎이 수거되었다. 수득된 고체를 실시예16에서와 동일한 방법으로 분석한 결과, (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 180㎎(수율:64%)이 수득된 것으로 나타났다.The organic layer was washed with water, and the solvent was distilled off under reduced pressure to collect 294.9 mg of solid. The obtained solid was analyzed in the same manner as in Example 16, and the result was (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one. 180 mg (yield: 64%) were obtained.

[실시예 26∼31][Examples 26 to 31]

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

실시예 16에서의 공정을 반복하여 실시하되, 테트라히드로푸란 1.6㎖ 대신에 이하의 표4에 나타내는 용매를 지정한 사용량으로 사용한다.The process in Example 16 was repeated, but instead of 1.6 ml of tetrahydrofuran, the solvent shown in Table 4 below was used at the specified amount.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 수율 및 4-디메틸아미노피리딘의 농도는 이하의 표4에 나타내는 바와 같다.The yield of the obtained (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one and the concentration of 4-dimethylaminopyridine are shown in the following table. It is as showing in 4.

[표 4]TABLE 4

Figure kpo00012
Figure kpo00012

[실시예 32]Example 32

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

(3R, 4R)-3-[(R)-1-t-부틸디메틸실릴옥시에틸]-4-트리메틸실릴옥시아제티딘-2-온 300㎎을 테트라히드로푸란 1㎖에 용해시킨 후, 혼합물을 -55℃로 냉각시킨다. 이어서, 물 0.005㎖(농도:0.5부피%), 아세트산 무수물 0.8㎖ 및 4-디메틸아미노피리딘 35㎎(농도:1.87중량%)을 가하고, 혼합물을 -55℃에서 69시간동안 교반한다. 반응이 완결된 후, 에틸아세테이트 20㎖ 및 NaHCO35% 수용액을 20㎖ 가하고 혼합물을 분리한다. 유기층을 물로 세정하고, 황산마그네슘으로 건조시킨 다음, 용매를 감압하에 증류제거하여 고체 265㎎이 수득되었다.After dissolving 300 mg of (3R, 4R) -3-[(R) -1-t-butyldimethylsilyloxyethyl] -4-trimethylsilyloxyazetidin-2-one in 1 ml of tetrahydrofuran, the mixture was dissolved. Cool to -55 ° C. Subsequently, 0.005 ml of water (concentration: 0.5% by volume), 0.8 ml of acetic anhydride and 35 mg of 4-dimethylaminopyridine (concentration: 1.87% by weight) are added, and the mixture is stirred at -55 ° C for 69 hours. After the reaction was completed, 20 ml of ethyl acetate and 20 ml of 5% aqueous NaHCO 3 solution were added and the mixture was separated. The organic layer was washed with water, dried over magnesium sulfate and the solvent was distilled off under reduced pressure to give 265 mg of a solid.

반응 혼합물을 고속 액체 크로마토그래피[컬럼:YMC-pak(A-303 0DS), 4.6×250㎜; 컬럼 온도:15℃, 용매:CH3CN/물=6/4(v/v), 유동율:1㎖/분, 검출:210㎚]로 분석한 결과, (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 212㎎(수율:78%)이 수득된 것으로 나타났다.The reaction mixture was subjected to high performance liquid chromatography [column: YMC-pak (A-303 0DS), 4.6 x 250 mm; Column temperature: 15 ° C., solvent: CH 3 CN / water = 6/4 (v / v), flow rate: 1 ml / min, detection: 210 nm]. As a result, (3R, 4R) -4-acetoxy 212 mg (yield: 78%) of 3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one were obtained.

[실시예 33]Example 33

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

실시예 16에서의 공정을 반복하여 실시하되, 물을 첨가하지 않는다. 4-디메틸아미노피리딘의 농도는 0.94중량%이도록 한다.The process in Example 16 was repeated but no water was added. The concentration of 4-dimethylaminopyridine is 0.94% by weight.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 수율은 40%이었다.The yield of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one obtained was 40%.

[실시예 34]Example 34

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one].

실시예 17에서의 공정을 반복하여 실시하되, 물을 첨가하지 않는다. 4-디메틸아미노피리딘의 농도는 1.38중량%이도록 한다.The process in Example 17 was repeated but no water was added. The concentration of 4-dimethylaminopyridine is 1.38% by weight.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시]아제티딘-2-온의 수율은 40%이었다.The yield of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxy] azetidin-2-one obtained was 40%.

[실시예 35]Example 35

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxy] azetidin-2-one].

실시예 17의 공정을 반복하여 실시하되, 물 0.005㎖ 대신에 물 0.005㎖(농도:3.03부피%)를 사용한다. 4-디메틸아미노피리딘의 농도는 1.35중량%이도록 한다.The process of Example 17 was repeated, but 0.005 ml of water (concentration: 3.03% by volume) was used instead of 0.005 ml of water. The concentration of 4-dimethylaminopyridine is 1.35% by weight.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시]아제티딘-2-온의 수율은 35%이었다.The yield of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxy] azetidin-2-one obtained was 35%.

[실시예 36]Example 36

[(3R, 4R)-4-아세톡시-3-[(R)-1-t-부틸디메틸실릴옥시]아제티딘-2-온의 제조].[Preparation of (3R, 4R) -4-acetoxy-3-[(R) -1-t-butyldimethylsilyloxy] azetidin-2-one].

실시예 19에서의 공정을 반복하여 실시하되, 아세트산 0.03㎖ 대신에 아세트산 0.15㎖(농도:8.57부피%)를 사용한다. 4-디메틸아미노피리딘의 농도는 1.29중량%이도록 한다.The process of Example 19 was repeated, but 0.15 ml of acetic acid (concentration: 8.57% by volume) was used instead of 0.03 ml of acetic acid. The concentration of 4-dimethylaminopyridine is 1.29% by weight.

수득된 (3R, 4R)-4-아세톡시-3-[(R)-1-(t-부틸디메틸실릴옥시)에틸]아제티딘-2-온의 수율은 37%이었다.The yield of (3R, 4R) -4-acetoxy-3-[(R) -1- (t-butyldimethylsilyloxy) ethyl] azetidin-2-one obtained was 37%.

상술한 실시예들내에서 사용한 성분들 외에도, 명세서내에 예시한 다른 성분들을 사용하여 반응을 실시하여도 실질적으로 동일한 결과들을 얻을 수 있다.In addition to the components used in the above-described embodiments, the same results can be obtained by carrying out the reaction using other components exemplified in the specification.

Claims (15)

하기 일반식(Ⅰ)을 갖는 β-락탐 화합물을 아세트산 무수물과 유기용매내에서 낮은 농도의 치환된 피리딘 존재하에 반응시킴을 특징으로 하는 하기 일반식(Ⅱ)를 갖는 4-아세톡시-3-하이드록시에틸아제티딘-2-온 유도체의 제조방법.4-acetoxy-3-hydride having the general formula (II) characterized by reacting a β-lactam compound having the general formula (I) in the presence of acetic anhydride and a low concentration of substituted pyridine Process for the preparation of oxyethylazetidin-2-one derivatives.
Figure kpo00013
Figure kpo00013
(식중, R1은 히드록실기에 대한 보호기이고, 및 R2, R3및 R4는 탄소 1∼6의 저급알킬기, 페닐기 또는 아르알킬기이다.)(Wherein R 1 is a protecting group for a hydroxyl group, and R 2 , R 3 and R 4 are lower alkyl, phenyl or aralkyl groups of 1 to 6 carbons.)
제 1 항에 있어서, 상술한 유기용매가 물 및 아세트산의 군으로부터 선택된 1종을 낮은 농도로 함유함을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.4. The 4-acetoxy-3-hydroxyethylazetidine-containing general formula (II) according to claim 1, wherein the organic solvent described above contains at least one selected from the group consisting of water and acetic acid. Method for preparing 2-one derivative. 제 1 항에 있어서, R1이 하기 일반식(Ⅲ)의 기임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing the 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein R 1 is a group represented by the following general formula (III).
Figure kpo00014
Figure kpo00014
(식중, R5, R6및 R7은 탄소수 1∼6의 저급알킬기이다.)(Wherein R 5 , R 6 and R 7 are lower alkyl groups of 1 to 6 carbon atoms).
제 1 항에 있어서, R1이 t-부틸디메틸실릴기임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing the 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein R 1 is a t-butyldimethylsilyl group. 제 1 항에 있어서, R1이 이소프로필디메틸실릴기임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The method for producing the 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein R 1 is an isopropyldimethylsilyl group. 제 1 항에 있어서, R1이 디메틸-1, 1, 2-트리메틸프로필실릴기임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.2. The 4-acetoxy-3-hydroxyethylazetidin-2-one derivative of formula (II) according to claim 1, wherein R 1 is a dimethyl-1, 1, 2-trimethylpropylsilyl group. Manufacturing method. 제 1 항에 있어서, R2, R3및 R4가 메틸기임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing the 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein R 2 , R 3 and R 4 are methyl groups. 제 1 항에 있어서, 상술한 치환된 피리딘이 4-디메틸아미노피리딘임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein the substituted pyridine is 4-dimethylaminopyridine. 제 1 항에 있어서, 상술한 치환된 피리딘이 4-피롤리디노피리딘임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein the substituted pyridine is 4-pyrrolidinopyridine. 제 1 항에 있어서, 상술한 치환된 피리딘이 4-피페리디노피리딘임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein the substituted pyridine is 4-piperidinopyridine. 제 1 항에 있어서, 반응계내의 상술한 치환된 피리딘의 농도가 0.2∼3중량%임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.2. The 4-acetoxy-3-hydroxyethylazetidin-2-one derivative of formula (II) according to claim 1, wherein the concentration of the above-mentioned substituted pyridine in the reaction system is 0.2 to 3% by weight. Manufacturing method. 제 2 항에 있어서, 용매내의 물의 농도가 0.1∼1.0부피%임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 2, wherein the concentration of water in the solvent is 0.1 to 1.0% by volume. 제 2 항에 있어서, 용매내의 아세트산의 농도가 0.6∼5.0부피%임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 2, wherein the concentration of acetic acid in the solvent is 0.6 to 5.0% by volume. 제 1 항에 있어서, 유기용매가 테트라히드로푸란임을 특징으로 하는 일반식(Ⅱ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (II) according to claim 1, wherein the organic solvent is tetrahydrofuran. 제 1 항에 있어서, 유기용매가 피리딘임을 특징으로 하는 일반식(Ⅲ)를 갖는 4-아세톡시-3-히드록시에틸아제티딘-2-온 유도체의 제조방법.The process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative having general formula (III) according to claim 1, wherein the organic solvent is pyridine.
KR1019870004232A 1986-04-30 1987-04-30 Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives KR910003612B1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP61101856A JPH0830057B2 (en) 1986-04-30 1986-04-30 Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JP61-101856 1986-04-30
JP101856 1986-04-30
JP270622 1986-11-13
JP61-270622 1986-11-13
JP27062286 1986-11-13
JP62-28942 1987-02-09
JP28942 1987-02-09
JP62028942A JPH0655717B2 (en) 1986-11-13 1987-02-09 Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative

Publications (2)

Publication Number Publication Date
KR870009994A KR870009994A (en) 1987-11-30
KR910003612B1 true KR910003612B1 (en) 1991-06-07

Family

ID=68469742

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870004232A KR910003612B1 (en) 1986-04-30 1987-04-30 Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives

Country Status (1)

Country Link
KR (1) KR910003612B1 (en)

Also Published As

Publication number Publication date
KR870009994A (en) 1987-11-30

Similar Documents

Publication Publication Date Title
US4914200A (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
EP0007973A1 (en) Process for the preparation of thienamycin and intermediates
EP0167154B1 (en) Process for preparing 4-acetoxy-3-hydroxyethylazetizin-2-one derivatives
KR910003612B1 (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
US4772683A (en) High percentage beta-yield synthesis of carbapenem intermediates
US4861877A (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
US4914199A (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
US4767853A (en) Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof
US4895939A (en) High percentage β-yield synthesis of carbapenem intermediates
JP2652047B2 (en) Method for producing 4-benzoyloxy-3-hydroxyethylazetidin-2-one derivative
US5399679A (en) (1'R,3S,4R)4-acylthio azetidinones
US6049009A (en) Production method of optically active trans-vinylsulfide alcohol
US4948885A (en) Synthesis of azetidinones
US5053502A (en) Anhydro penicillin derivatives
US5075438A (en) Synthesis of azetidinones
KR950005913B1 (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
JP2604794B2 (en) Method for producing 4-acetoxy-3-hydroxyethylazetidin-2-one
JPH0655717B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JPH0557264B2 (en)
JPH0830057B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JPH06784B2 (en) 2,6-Epoxy-3,4,5,6-tetrahydro-2H-naphthaleno [1,2-b] oxocin-9,12-dione derivative
EP0204440A1 (en) Azetidine derivatives production
JPH05239020A (en) Production of 3-(r)-1-(substituted-oxycarbonyloxy) ethyl)-4-substituted-2-azetidinone
JPH0730016B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JPH09301975A (en) Pyrroloquinoline derivative

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990531

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee